版本:
中国

BRIEF-Vistagen Therapeutics says European Patent Office has issued a notice of intention to grant company's European patent application for AV-101

March 29 Vistagen Therapeutics Inc

* Vistagen Therapeutics says European Patent Office (EPO) has issued a notice of intention to grant company's European patent application for AV-101 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐